Literature DB >> 15925116

Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate.

Maria Julia Marques1, Marcus Alexandre Mendes Luz, Elaine Minatel, Humberto Santo Neto.   

Abstract

Activation of muscle satellite cells, a fundamental step in the success of muscle regeneration is mediated by nitric oxide (NO). In this study, we investigated whether isosorbide dinitrate (ISD), an NO donor, could improve muscle regeneration in dystrophic mdx mice. The right tibialis anterior muscle of mdx and C57Bl/10 mice was injected with bupivacaine (0.3 ml, 33 mg/kg), a myotoxic agent, to induce muscle fiber regeneration. After bupivacaine injection, mice were treated with ISD (30 mg/kg; i.p.), verapamil (a non-NO donor vasodilator, 15 mg/kg, i.p.) or saline solution (vehicle, 0.3 ml, i.p.) for 20 days. Some bupivacaine-injected mice received no pharmacological treatment (control group). Muscle regeneration was evaluated by counting the total number of muscle fibers and measuring myofiber cross-sectional area. ISD significantly improved bupivacaine-induced muscle regeneration in mdx by increasing by 20% the total number of muscle fibers compared to the other groups. Spontaneous muscle regeneration, evaluated in the contralateral non-injected muscle, was not affected. ISD treatment did not affect myofiber cross-sectional area. Verapamil and saline had no effect on muscle regeneration. These results suggested that NO derived from ISD stimulated and/or recruited satellite cells. Pharmacological treatment with ISD could be clinically useful for improving muscle regeneration in Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925116     DOI: 10.1016/j.neulet.2005.03.023

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Characteristics of muscle fibers reconstituted in the regeneration process of masseter muscle in an mdx mouse model of muscular dystrophy.

Authors:  Won-Hyung Lee; Shinichi Abe; Hee-Jin Kim; Akinobu Usami; Atsuro Honda; Koji Sakiyama; Yoshinobu Ide
Journal:  J Muscle Res Cell Motil       Date:  2006-06-04       Impact factor: 2.698

2.  Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.

Authors:  Clara Sciorati; Roberta Buono; Emanuele Azzoni; Silvana Casati; Pierangela Ciuffreda; Grazia D'Angelo; Dario Cattaneo; Silvia Brunelli; Emilio Clementi
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy.

Authors:  Michael D Nelson; Ryan Rosenberry; Rita Barresi; Evgeny I Tsimerinov; Florian Rader; Xiu Tang; O'Neil Mason; Avery Schwartz; Thomas Stabler; Sarah Shidban; Neigena Mobaligh; Shomari Hogan; Robert Elashoff; Jason D Allen; Ronald G Victor
Journal:  J Physiol       Date:  2015-11-02       Impact factor: 5.182

4.  The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration.

Authors:  Cristina Borselli; Christine A Cezar; Dymitri Shvartsman; Herman H Vandenburgh; David J Mooney
Journal:  Biomaterials       Date:  2011-09-10       Impact factor: 12.479

5.  A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy.

Authors:  Clara Sciorati; Daniela Miglietta; Roberta Buono; Viviana Pisa; Dario Cattaneo; Emanuele Azzoni; Silvia Brunelli; Emilio Clementi
Journal:  Pharmacol Res       Date:  2011-05-12       Impact factor: 7.658

6.  The effects of bupivacaine injection and oral nitric oxide on extraocular muscle in the rabbit.

Authors:  Burak Bilgin; Huseyin Gursoy; Hikmet Basmak; Mete Ozkurt; Nese Tuncel; Funda Canaz; Serap Isiksoy; Ertugrul Colak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-04       Impact factor: 3.117

7.  Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.

Authors:  Jose R Lopez; A Uryash; J Kolster; E Estève; R Zhang; J A Adams
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

Review 8.  Nitric oxide in myogenesis and therapeutic muscle repair.

Authors:  Clara De Palma; Emilio Clementi
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

9.  Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.

Authors:  Daniela Miglietta; Clara De Palma; Clara Sciorati; Barbara Vergani; Viviana Pisa; Antonello Villa; Ennio Ongini; Emilio Clementi
Journal:  Orphanet J Rare Dis       Date:  2015-08-22       Impact factor: 4.123

Review 10.  Functional muscle ischemia in Duchenne and Becker muscular dystrophy.

Authors:  Gail D Thomas
Journal:  Front Physiol       Date:  2013-12-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.